Brain PET & SPECT (Visualize the Malfunctioning Brain

Dates and Times

Start: 1/31/2023 12:00 PM
End: 1/31/2023 1:00 PM

Objectives

After the presentation the viewers should be able to:
Learning Objectives:  Recent progress in the development and translation of molecular imaging techniques for the purpose of advanced diagnosis and treatment of neurodegenerative disorders.

                                   Development of two specific imaging markers that have been developed in our lab, one for detention and quantification of amyloid deposition in Alzheimer's disease and one for myelin damage in myelin                                                 damage in multiple and spinal cord injury.  Both imaging markers have been successfully translated from benchtop to the bedside of patients, enabling their use in clinical studies

Educational objective: Use of these imaging markers in evaluating the efficacy of therapeutic interventions currently under development for these conditions

                                     Use of molecular and functional imaging techniques to provide valuable insights into the underlying mechanisms of neurodegenerative disorders.                                    

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.